MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'asenapine'. Sat, 03 Sep 2011 02:39:16 +0100 http://www.medworm.com/index.php?rid=2967524&cid=t_158319_150_f&fid=34768&url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2009%2F11%2Fmerck-saphris-now-heres-something-you.html Page 897 (Source: PharmaGossip) PharmaGossip blogs http://www.medworm.com/rss/comments.php?id=2967524 Fri, 06 Nov 2009 09:30:00 +0100 2967524 http://www.medworm.com/index.php?rid=2702400&cid=t_158319_122_f&fid=34755&url=http%3A%2F%2Fneuropsychological.blogspot.com%2F2009%2F08%2Ffda-saphris-asenapine-approval.html From the FDA:FDA Approves Saphris to Treat Schizophrenia and Bipolar DisorderThe U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.“Mental illnesses like schizophrenia and bipolar disorder can be devastating to patients and families, requiring lifelong treatment and therapy,” said Thomas Laughren, M.D., director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research. “Effective medicines can help people with mental illness live more independent lives.”Read the full FDA press releaseS-P corporat... BrainBlog blogs http://www.medworm.com/rss/comments.php?id=2702400 Fri, 14 Aug 2009 20:54:00 +0100 2702400 http://www.medworm.com/index.php?rid=1312485&cid=t_158319_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F253892123%2F Another busy day draws to a close. And so the time has come for us to check on how the short people are faring with their after-school sports and curl up in front of the telly with the shortest one of all. Of course, first we must feed the dog. Meanwhile, we hope your day was productive and you do something fun this evening… The FDA is warning that Spiriva, a drug for COPD, or chronic obstructive pulmonary disease, which is marketed jointly Pfizer and Boehringer Ingelheim, may increase the risk of a stroke. In a statement on its web site, the FDA says a preliminary analysis by Boehringer of about 13,500 patients from 29 clinical studies found that the risk of a stroke was 8 in 1,000 patients taking the inhaled drug, compared with 6 in 1,000 who took a placebo. This means that the est... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1312485 Wed, 19 Mar 2008 03:17:01 +0100 1312485 http://www.medworm.com/index.php?rid=1096193&cid=t_158319_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F200408651%2Fscheringplough.html Last but not least is Schering-Plough who falls 15th on the r&d budget list ($1.65 bn EUR) and 16th in over all sales for 2006. After a number of bad years Schering has put itself back in the running with various moves that have revitalized its drug pipeline. Those moves include the purchase of Azko Nobel’s Organon which added five late-stage drugs to the pipeline. Also, the FDA recently accepted Schering’s application for asenapine which is indicated for schizophrenia and bipolar disorder. Pending Approval: ASMANEX - Asthma (Japan), Pediatric Asthma CLARITIN/Singulair2 - Seasonal Allergic Rhinitis NASONEX - Allergic Rhinitis (Japan) NOXAFIL - Serious Fungal Infections Phase III: Acadesine - Ischemia-Reperfusion InjuryASENTAR - Prostate CancerGolimumab (CNTO 148) - Rhe... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1096193 Thu, 13 Dec 2007 19:00:06 +0100 1096193 http://www.medworm.com/index.php?rid=1054848&cid=t_158319_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F191462750%2Ffda_drug_approval_news.html Vanada Pharmaceuticals has announced that its drug, iloperidone, has been accepted for U.S. Food and Drug Administration New Drug Application (NDA). Iloperidone is an investigational atypical antipsychotic for the treatment of schizophrenia.In other FDA news, Watson Pharmaceuticals Inc announced that it received final approval on its ANDA for Oxycodone Hydrochloride and Ibuprofen tablets in the 5/400 mg strengths. Waston's product is the generic equivalent of Forest Laboratories Inc.'s Combunox which is used for the short term (no more than 7 days) treatment of acute, moderate to severe pain.The FDA has accepted filing of a NDA for Schering-Plough's asenapine, a fast-dissolving, sub-lingual tablet for schizophrenia and acute mania associated with Bipolar I Disorder. To dat... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1054848 Tue, 27 Nov 2007 20:00:38 +0100 1054848